Voices
Yüksel Ürün: sMAdCAM-1 as a Prognostic Biomarker for PFS and OS in Metastatic Renal Cell Carcinoma
Yüksel Ürün/X

Yüksel Ürün: sMAdCAM-1 as a Prognostic Biomarker for PFS and OS in Metastatic Renal Cell Carcinoma

Yüksel Ürün, Medical Oncology Professor at Ankara University School of Medicine, shared a post on X about a recent article by Carolina Alves Costa Silva et al, published in Nature Medicine:

“Across 1,051 patients baseline sMAdCAM-1 >180 ng/mL linked to better PFS and OS, independent of IMDC. Low levels tracked Enterocloster-rich dysbiosis!”

Title: Soluble MAdCAM-1 as a biomarker in metastatic renal cell carcinoma

Authors: Carolina Alves Costa Silva, Marc Machaalani, Renee Maria Saliby, Caiwei Zhong, Wanling Xie, Edoardo Pasolli, Gianmarco Piccinno, Cécile Dalban, Marine Fidelle, Aurelia Meurisse, Dewi Vernerey, Gwo-Shu Mary Lee, Roxanne Birebent, Eddy Saad, Clara Steiner, Ronan Flippot, Janice Barros-Monteiro, Nicola Segata, Antoine Thiery-Vuillemin, Silvia Formenti, Tatiana Kuznetsova, Bernard Escudier, Lisa Derosa, Laurence Zitvogel, Toni K. Choueiri, Laurence Albiges

Read the Full Article on Nature Medicine  

Yüksel Ürün: sMAdCAM-1 as a Prognostic Biomarker for PFS and OS in Metastatic Renal Cell Carcinoma

More posts featuring Renal Cell Carcinoma.

 

Antoine Thiery-Vuillemin Aurelia Meurisse Bernard Escudier Caiwei Zhong cancer Carolina Alves Costa Silva Cécile Dalban Clara Steiner Dewi Vernerey Eddy Saad Edoardo Pasolli Gianmarco Piccinno Gwo-Shu Mary Lee Janice Barros-Monteiro Laurence Albiges Laurence Zitvogel Lisa Derosa Marc Machaalani Marine Fidelle Nicola Segata OncoDaily Oncology renal cell carcinoma Renee Maria Saliby Ronan Flippot Roxanne Birebent Silvia Formenti Tatiana Kuznetsova Toni K. Choueiri Wanling Xie Yüksel Ürün